Remove development Remove digital therapeutics Remove enablement Remove investing
article thumbnail

Digital therapeutics startup Neuroglee raises $10M to help people with neurodegenerative conditions

TechCrunch

Neuroglee Therapeutics , a startup developing digital therapeutics for people with neurodegenerative diseases, has raised a $10 million Series A led by Openspace Ventures and EDBI. million to develop digital therapeutics for neurodegenerative diseases. Venture investing in elder tech.

article thumbnail

BrainCheck brings in another $10M to detect, manage cognitive impairment

TechCrunch

BrainCheck , a Houston- and Austin-based company developing cognitive healthcare software to aid physicians in detecting and managing this type of care, raised $10 million in Series B funding to expand its R&D and go-to-market capabilities as it works on new digital therapeutics for Alzheimer’s and related dementias.

article thumbnail

Biofourmis hits unicorn status after $300m Series D funding

AsiaTechDaily

Register Biofourmis , a Sigapore-founded digital therapeutics firm , announced that it has surpassed unicorn status with a $300 million Series D investment led by leading global growth equity firm General Atlantic. With this investment, Biofourmis plans to scale up its virtual care offerings, according to the announcement.